Breaking News
Get 45% Off 0
🤖 Are you in? These 5 AI-picked stocks are up 15%+
Read article

Stock Markets Analysis & Opinion

Contribute
Zacks Investment Research
Boston Scientific Fortifies Pain Therapy Arm With FDA Nod By Zacks Investment Research - Jan 14, 2018

Boston Scientific (NYSE:BSX) is hitting headlines with successive new developments, the latest feat being the company’s Spectra WaveWriter Spinal Cord Stimulator System (SCS) getting an FDA...

Zacks Investment Research
GoDaddy (GDDY) Benefits From Strong Portfolio, Risks Persist By Zacks Investment Research - Jan 14, 2018

On Jan 12, we issued an updated research report on GoDaddy Inc. (NYSE:GDDY) .GoDaddy is engaged in the designing and development of cloud-based technology products for small businesses, Web design...

Zacks Investment Research
Here's Why It's Wise To Add Hyatt Stock To Your Portfolio By Zacks Investment Research - Jan 14, 2018

Hyatt Hotels Corporation (NYSE:H) , which is currently one of the best-performing stocks in the hotel space, has strong fundamentals. Robust share price appreciation along with a Zacks Rank #1...

Zacks Investment Research
Express Scripts 90-Day Analysis Of Opioid Management Positive By Zacks Investment Research - Jan 14, 2018

In an initiative to reduce excessive opioid prescribing, Express Scripts Holding Company (NASDAQ:ESRX) announced a 90-day analysis of its Advanced Opioid Management program.The program was initiated...

Zacks Investment Research
NETGEAR Hits 52-Week High, Expanding Portfolio Key Catalyst By Zacks Investment Research - Jan 14, 2018

Shares of NETGEAR Inc. (NASDAQ:NTGR) rallied to a new 52-week high of $65.55, eventually closing a tad lower at $65.40 on Jan 12.The stock has returned 18.3% in the past year, underperforming the...

Zacks Investment Research
Glaxo's Influenza Vaccine Gets FDA Nod For Label Expansion By Zacks Investment Research - Jan 14, 2018

GlaxoSmithKline plc (NYSE:GSK) received approval from the FDA’s Center for Biologics Evaluation and Research for the label expansion of influenza vaccine — FluarixQuadrivalent. The...

Zacks Investment Research
5 Reasons Why You Should Buy Lam Research (LRCX) Stock Now By Zacks Investment Research - Jan 14, 2018

Lam Research Corporation (NASDAQ:LRCX) is currently one of the top-performing stocks in the technology sector and an increase in share price and strong fundamentals signal its bullish run....

Zacks Investment Research
Raytheon Unit Wins $642M Deal For Ballistic Missile Test By Zacks Investment Research - Jan 14, 2018

Raytheon Company’s (NYSE:RTN) Integrated Defense Systems (IDS) business segment recently secured a contract worth $641.6 million to perform Ballistic Missile Defense System (BMDS) test related...

Zacks Investment Research
Will Vending Machines Boost Fastenal's (FAST) Q4 Earnings? By Zacks Investment Research - Jan 14, 2018

Fastenal Company (NASDAQ:FAST) is scheduled to report fourth-quarter fiscal 2017 results on Jan 17, before the opening bell.Increased installation of industrial vending machines is expected to boost...

Zacks Investment Research
Henry Schein (HSIC) Buys ABASE, Expands In Animal Health By Zacks Investment Research - Jan 14, 2018

Henry Schein, Inc. (NASDAQ:HSIC) recently announced the purchase of a 60% stake in veterinary product distributor — ABASE — under certain undisclosed financial terms. Per the company,...

Zacks Investment Research
3 Pharma And Biotech Stocks To Watch Out For In 2018 By Zacks Investment Research - Jan 14, 2018

2017 turned out to be a pretty good year for pharma and biotech stocks with the Nasdaq Biotechnology index and the NYSE ARCA Pharmaceutical index gaining 18.7% and 11.8%, respectively. Although the...

Continue with Apple
Continue with Google
or
Sign up with Email